世界のアスピリン市場 – 業界動向と2030年までの予測

アスピリン市場の分析と規模

アスピリンは、COX依存性および非依存性メカニズムに効果を発揮するため、がん、糖尿病、クリプトコッカス感染症、神経系障害など、さまざまな疾患の予防に使用できます。医療提供者は、どの年齢層にアスピリンを推奨するか、または心臓発作や脳卒中の一次予防に処方するかという問題に直面しています。カーディナルヘルスなどのアスピリンの使用法の開発により、アスピリンを添加剤として使用したハイドロゲルが処方されました。アスピリンを成分としても使用する新しい処方により、アスピリンの市場成長が促進される可能性があります。                             

データブリッジ市場調査は、アスピリン市場は予測期間中に3.10%のCAGRで成長すると予測しています。人口の心臓疾患の増加により、アスピリン市場の投与経路セグメントでは「経口」が主流となっています。市場価値、成長率、セグメンテーション、地理的範囲、主要プレーヤーなどの市場シナリオに関する洞察に加えて、データブリッジ市場調査がまとめた市場レポートには、詳細な専門家分析、患者の疫学、パイプライン分析、価格分析、規制枠組みも含まれています。

アスピリン市場の範囲とセグメンテーション

Market Definition

Aspirin also known as acetylsalicylic acid which is mostly use as antipyretic,analgesic and anti-coagulant and is clinically used by the population over 100 years. It is also used in the prevention of cardiovascular disease. It is a cyclooxygenase (COX-1) inhibitor and can modify the enzymatic activity of cyclooxygenase-2 (COX-2). It irreversibly binds with this enzyme and also blocks the thromboxane A2 on platelet therefore, preventing the platelet aggregation.

Aspirin Market Dynamics

Drivers

• Increasing prevalence of cardiovascular diseases

Heart attacks and strokes are two common cardiovascular disorders that aspirin is frequently used to treat and prevent. Aspirin is becoming more and more popular as a therapy option and a preventive measure as these disorders become more prevalent globally. Thus increase in the incidence rates of cardiac diseases is acting as driver for the market growth.

• Technological advancements in drug delivery systems

The creation of aspirin formulations with a variable release time has been made possible by technological developments in drug delivery systems. These aspirin formulations offer controlled aspirin release, enabling once-daily dosing and possibly minimising gastrointestinal adverse effects. These developments improve patient adherence and support the expansion of the aspirin market.

• Rising geriatric population

As the global population ages, age-related illnesses including cardiovascular disease and arthritis are becoming more common. Since aspirin is frequently used to treat these problems. Henceforth, growing ageing population across the globe demonstrates the future growth of the market.

Opportunities

• Increasing R&D activities

Aspirin is being used in innovative ways that go beyond its conventional uses thanks to ongoing research and clinical trials. Aspirin's potential for preventing cancer, especially colorectal cancer, and its function in reducing the risk of preeclampsia in expectant women are receiving more attention. These potential uses can create new aspirin market niches and possibilities if they are further validated.

• Increasing strategic collaborations and partnership

Innovation, research acceleration, and market penetration can all be improved by partnerships between pharmaceutical corporations, academic institutions, and healthcare organisations. Partnerships open up chances for market expansion by promoting the creation of novel formulations, combination medicines, and a wider geographic reach.

Restrains/ Challenges

• Availability of alternative therapies

The demand for aspirin may be affected by the availability of complementary medicines, such as other nonsteroidal anti-inflammatory medications (NSAIDs) and pain management choices. In order to prevent the aspirin market from expanding too much, patients and medical professionals may decide to use other drugs or therapies based on their efficacy, safety profile, patient preferences, and cost-effectiveness.

• Safety concerns and adverse effects

Although aspirin is typically well accepted, it can have unwanted consequences such gastrointestinal bleeding, ulcers, and a higher risk of bleeding. Some people may choose not to use aspirin or limit its long-term use due to these safety worries and side effects related to its use. Both people and medical professionals may be influenced by the possible dangers and side effects while making decisions.  Thus, safety concerns and adverse effects may hamper the market growth.

• Strict regulatory framework

Like all medications, aspirin is subject to tight regulatory standards and limitations on labelling. For consumers, these regulations guarantee safety, efficacy, and accurate information. However, aspirin producers may experience operational and financial difficulties as a result of complying with constantly changing laws and label changes. Thus it is predicted that strict regulations is the major key challenge for the future growth of the market.

This aspirin market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the biomarkers market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

Recent Development

• Bayer announced in December 2021, that it will deploy €100 million to enable more sustainable research, manufacture, and utilization of its Consumer Health supplements, which include global names including Aspirin, Bepanthen, Claritin, and Elevit.

Global Aspirin Market Scope

The aspirin market is segmented on the basis of route of administration, dosage form, applications, dose type, availability, product type, end-user and distribution channel. The growth among segments helps you analyse niche pockets of growth and strategies to approach the market and determine your core application areas and the difference in your target markets.

Route of administration

• Oral
• Rectal
• Parenteral

Dosage form

• Tablets
• Effervescent
• Chewable
• Film Coated
• Extended release
• Delayed release
• Enteric coated tablets
• Capsules
• Extended release
• Injections
• Intravenous injections
• Suppositories

Applications

• Pain
• Fever and inflammation
• Deep vein thrombosis
• Others

Dose type

• Adult dose
• Pediatric dose

Availability

• Prescription
• OTC

Product type

• Alone
• Combination products

End user

• Hospitals
• Clinics
• Others

Distribution Channel

• Hospital pharmacies
• Online pharmacies
• Retail pharmacies

Aspirin Market Regional Analysis/Insights

Global aspirin market is analysed and market size information is provided by country, route of administration, dosage form, applications, dose type, availability, end-user and distribution channel as referenced above.

The countries covered in the aspirin market report are the U.S., Canada, Mexico in North America, Brazil, Argentina, Peru, Rest of South America, as part of South America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Hungary, Lithuania, Austria, Ireland, Norway, Poland, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Vietnam, Rest of Asia-Pacific, Saudi Arabia, U.A.E, Egypt, Israel, Kuwait, South Africa, Rest of Middle East and Africa, as a part of Middle East and Africa.

Asia-Pacific  is expected to dominate the market due to the low cost and increase in government support. Europe is expected to grow owing the increased number of cases of migraine.

The country section of the report also provides individual market impacting factors and changes in regulations in the market domestically that impacts the current and future trends of the market. Data points such as new sales, replacement sales, country demographics, disease epidemiology and import-export tariffs are some of the major pointers used to forecast the market scenario for individual countries. Also, presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of sales channels are considered while providing forecast analysis of the country data.   

Healthcare Infrastructure growth Installed base and New Technology Penetration

The aspirin market also provides you with detailed market analysis for every country growth in healthcare expenditure for capital equipment, installed base of different kind of products for aspirin market, impact of technology using life line curves and changes in healthcare regulatory scenarios and their impact on the aspirin market. The data is available for historic period 2010-2021.

競争環境とアスピリン市場シェア分析

アスピリン市場の競争状況は、競合他社ごとに詳細を提供します。含まれる詳細には、会社概要、会社の財務状況、収益、市場の可能性、研究開発への投資、新しい市場への取り組み、世界的なプレゼンス、生産拠点と施設、会社の強みと弱み、製品の発売、臨床試験パイプライン、製品の承認、特許、製品の幅と広さ、アプリケーションの優位性、技術ライフライン曲線などがあります。提供されている上記のデータ ポイントは、アスピリン市場に関連する会社の焦点にのみ関連しています。

アスピリン市場で活動している主要企業は次のとおりです。

• バイエルAG（ドイツ）
• グローバルインポーター株式会社（中国）
• アレジアント・ヘルス（米国）
• パーファーマシューティカル（米国）
• アナスタシオ化学（ブラジル）
• カーディナルヘルス（米国）
• 南京ファーマテックス株式会社（中国）
• JQC（華陰）製薬有限公司（中国）
• LNKインターナショナル社（米国）
• Globela Pharma Pvt Ltd (インド)
• バルファーマリミテッド（インド）
• トゥルマックヘルスケア（インド）
• ペリゴ カンパニー plc (アイルランド)
• アルタラボラトリーズ社（インド）
• 鎮江高鵬製薬有限公司（中国）
• セケンス（フランス）
• ウマン・ファーマテック株式会社（インド）
• JM Loveridge Ltd (英国)
• メインファーマグループリミテッド（オーストラリア）
• セントジョセフアスピリン（米国）

SKU-59695